Oxford BioDynamics Plc (AIM:OBD)
London · Delayed Price · Currency is GBP · Price in GBX 0.1738
-0.0062 (-3.44%)
Jun 16, 2026, 12:03 PM GMT
Oxford BioDynamics Market Cap
Oxford BioDynamics has a market cap or net worth of 7.72 million as of June 16, 2026. Its market cap has decreased by -12.32% in one year.
Market Cap
7.72M
Enterprise Value
11.44M
Revenue
1.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.17
Market Cap Chart
Since December 6, 2016, Oxford BioDynamics's market cap has decreased from 136.90M to 7.72M, a decrease of -94.36%. That is a compound annual growth rate of -26.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 7.72M | -16.28% |
| Dec 31, 2025 | 9.23M | 92.61% |
| Dec 31, 2024 | 4.79M | -91.54% |
| Dec 29, 2023 | 56.64M | 125.13% |
| Dec 30, 2022 | 25.16M | -34.45% |
| Dec 31, 2021 | 38.38M | -50.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 6, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptamer Group | 18.14M |
| Palatin Technologies | 16.83M |
| Fusion Antibodies | 14.69M |
| Cizzle Biotechnology Holdings | 13.39M |
| Genflow Biosciences | 12.04M |
| OptiBiotix Health | 6.40M |
| CRISM Therapeutics | 5.69M |
| Nuformix | 5.35M |